NCT01062477View on ClinicalTrials.gov

A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

1,056

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

December 31, 2011

Conditions
DiphtheriaTetanusPertussisHaemophilus Influenzae Type B
Interventions
BIOLOGICAL

DTaP//PRP-T Combined Vaccine

0.5 mL, Intramuscular

BIOLOGICAL

DTaP//PRP-T Combined Vaccine

0.5 mL, Intramuscular

BIOLOGICAL

DTaP Combined Vaccine and PRP-Tetanus Conjugate Vaccine

0.5 mL, Intramuscular (each vaccine)

Trial Locations (2)

541200

LingChuan County, Guilin City

546600

Lipu County, Guilin City

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY